Genes study will bring 'new era' in medicine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The world's largest study into the role played by genes and lifestyle in illness could lead to a new era of medical treatment, its backers claimed yesterday.
Professor George Radda, chief executive of the Medical Research Council, said the UK biobank project could lead to drugs designed specifically for individuals within 20 years.
Sir George was speaking as the MRC, the Wellcome Trust charity and the Department of Health announced an initial grant of £45m for the research.
Biobank, which could begin recruiting volunteers this year, aims to monitor the health of up to 500,000 middle-aged Britons over many years, correlating their health, lifestyle and genes.
Researchers hope to find the relative influence of genes and environmental factors in predisposing people to illnesses such as heart disease or cancer. Sir George said the funding would enable a project that could "herald a new era of medicine".
"In 20 years' time, we may see individualised approaches to disease prevention and treatment. Once we understand the genetic bases of various diseases and the genetic differences between individuals that may affect their responses, it may become possible for a GP to prescribe drugs or other treatments designed specifically for people's own genetic make-up," he said.
The project has been criticised over the safeguards to ensure the genetic data it holds remain private and were not open to commercial exploitation. But Dr Mike Dexter, director of the Wellcome Trust, said he would be personally willing to donate his DNA to the study. "I may not reap the health benefits in my lifetime, but those of us contributing to the project can rest assured that our involvement will provide a better life for our children and grandchildren," he said.
Similar gene banks have been set up in other countries, but not with so many people or in a population with such genetic diversity.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments